Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent Tue, 26 Jul 2005 Patients the world over need adeaquate protection from overreaching physicians who use patients to test experimental drugs and procedures without their informed consent. Jacques Michel, a retired director of Hadassah Hospital in Jerusalem who also…
Recent developments in gene transfer research: risk and ethics Mon, 10 Jan 2005 An analysis by Dr. Jonathan Kimmelman, in the British Medical Journal provides an illuminating, clearly articulated discussion about the ethical dilemmas that challenge gene transfer experiments – essentially a kind of human genetic engineering involving somatic cells,…
July 08, 2002 Critique: U.S. to Vaccinate 500,000 Workers Against Smallpox 7 Jul 2002 FYI Dr. Meryl Nass, a member of the board of The Alliance for Human Research Protection and a recognized expert on Gulf War Syndrome and the use and consequences of experimental vaccines, raises serious concerns about…
NHLBI director Dr. Lenfant is Retiring Thu, 3 Jul 2003 The retirement of Dr. Claude Lenfant, director of the National Heart, Lung, and Blood Institute (NHLBI) was announced today. Not mentioned in the press release is the heated controversy surrounding two clinical trials sponsored by the NHLBI, conducted by the…
Suffer the Little Children in the Research for Cures_USA Today Thu, 29 May 2003 USA Today focuses on safety issues affecting children who are being sought as human guinea pigs by the thousands. They are being recruited clinical trials to test new drugs– whose safety is unproven. “Was the death…
Maryland Court of Appeals Denies Motion to Reconsider Lead Paint Ruling October 10, 2001 FYI Maryland’s highest court denied the motion for reconsideration or partial modification of its Opinion–as requested by Kennedy Krieger Institute and their powerful allies in the research community (who filed Amicus briefs in support of defendants’…
Analysis of 94 OHRP Letters of Determination, July 1, 2000 to January 31, 2001 Research Compliance Note. Thomas Dalglish, JD, PhD * The views expressed in the ‘Research Compliance Note’ below are the personal opinions of the author, do not reflect any official position of the University of Washington, and…
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
Someone Tell Brooke Shields the Truth!! Mon, 4 Jul 2005 On this American independence day, thousands of families strive for drug free schools–and they’re not worrying about illegal drugs, their main concern is coercive prescribed amphetamines and other mind-altering psychotropic drugs. Other than the critical reaction of actor Tom Cruise,…
Researcher Who Challenged ADHD industry cleared of misconduct charges Sun, 16 Oct 2005 If you thought that academia could not prey to McCarthyite bullying tactics–or could not possibly fall prey to anything like the Salem witch hunts—think again. Dr. Gretchen LeFever, a clinical psychologist and associate professor in the department…
Judge Bars Military from Forced Anthrax Vaccine – Victory for Infomed Consent Doctrine Thu, 28 Oct 2004 On October 27, a federal court ruled against the US government for violating the right of military personnel to informed consent. U.S. District Judge Emmet G. Sullivan ruled that the “involuntary anthrax vaccination…
July 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Wall Street Journal reports that there is a shortage of people volunteering to test experimental cancer drugs. “Overall, only 3% to 4% of cancer patients participate in trials. Most of those participants are…
